Inclusion Criteria:

• Female participants.
• Age between 18 and 60 years.
• Body mass index (BMI) between 27.0 and 39.9 kg/m².
• No regular participation in yoga, meditation, breathing exercises, structured relaxation programs, or similar mind-body practices within the previous 3 months.
• No initiation of a structured weight-loss program within the previous 3 months.
• Able to attend weekly intervention sessions, modules, and study assessments.
• Willing to refrain from starting any new exercise, yoga, meditation, diet, or weight-loss program during the study.
• Able and willing to provide written informed consent.

Exclusion Criteria:

• BMI ≥40 kg/m².
• Uncontrolled hypertension or severe cardiovascular disease.
• Cardiac arrhythmia, pacemaker, or other cardiac conditions that may affect heart rate variability (HRV).
• Regular use of beta-blockers, antiarrhythmic agents, or other medications that substantially affect HRV (including medications affecting heart rate/rhythm, anticholinergic drugs, tricyclic antidepressants, and stimulant/sympathomimetic medications).
• Neurological disease.
• Uncontrolled thyroid disease or uncontrolled metabolic/endocrine disorders.
• Pregnancy or breastfeeding.
• History of bariatric surgery.
• Initiation of weight-loss medication or GLP-1 receptor agonist therapy within the previous 6 months.
• Current or clinically diagnosed anorexia nervosa, bulimia nervosa, binge eating disorder, or other eating disorders requiring active treatment (emotional eating alone is not an exclusion criterion).
• Psychological or psychiatric conditions that would interfere with safe participation.
• Diagnosed obstructive sleep apnea or untreated severe sleep disorders.
• Regular tobacco or nicotine product use within the previous 3 months.
• Musculoskeletal conditions preventing participation in the intervention.
• Cardiopulmonary or orthopedic limitations that make exercise unsafe.